ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products.

RECENT NEWS

ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis

2026-07-13

READ MORE >

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

2026-05-27

READ MORE >

NASDAQ - ANIP

$81.92

+1.1 ( 1.36% )

Pricing delayed by 20 minutes
Last updated